Related Experiment Video

Updated: Sep 30, 2026

The Mouse Forced Swim Test
06:19

The Mouse Forced Swim Test

Published on: January 29, 2012

The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian

T Egashira1, F Takayama, Y Yamanaka

  • 1Department of Pharmacology, Oita Medical University, Japan.

Japanese Journal of Pharmacology
|December 2, 1999
PubMed

Insights

Antidepressant drugs differentially inhibit monoamine oxidase (MAO) A and B activities across species. Monkey brains show higher sensitivity to these drugs compared to rodent brains.

Area of Science:

  • Neuropharmacology
  • Biochemistry
  • Enzymology

Background:

  • Mitochondrial monoamine oxidase (MAO) enzymes are crucial for neurotransmitter metabolism.
  • Antidepressant drugs target MAO enzymes, but their inhibitory profiles vary.
  • Species-specific differences in MAO activity and drug interactions are not fully understood.

Purpose of the Study:

  • To compare the in vitro effects of four antidepressant drugs (zimeldine, imipramine, maprotiline, nomifensine) on MAO-A and MAO-B activities in different animal brains.
  • To elucidate the inhibitory mechanisms and determine the potency of these drugs across species.

Main Methods:

  • In vitro enzyme inhibition assays were performed on mitochondrial extracts from mouse, rat, dog, and monkey brains.
  • The activities of MAO-A and MAO-B were measured in the presence of varying concentrations of the antidepressant drugs.
  • Inhibition kinetics (competitive vs. noncompetitive) and inhibition constants (Ki) were determined.

Main Results:

  • Zimeldine preferentially inhibited MAO-B in rodent brains, while imipramine showed mixed inhibition patterns depending on concentration and species.
  • Maprotiline and nomifensine predominantly inhibited MAO-B in rodents but MAO-A in dogs and monkeys.
  • All tested drugs acted as competitive inhibitors of MAO-A and noncompetitive inhibitors of MAO-B.
  • Monkey brain MAO enzymes exhibited lower Ki values, indicating greater sensitivity to the tested antidepressant drugs compared to rodent brains.

Conclusions:

  • Antidepressant drugs display distinct inhibitory profiles against MAO-A and MAO-B, which are species-dependent.
  • Monkey MAO enzymes are significantly more sensitive to inhibition by these antidepressant drugs than those found in rodent brains.
  • These findings highlight the importance of considering species differences in MAO activity when evaluating antidepressant drug efficacy and potential side effects.

More Related Videos

The Tail Suspension Test10:17

The Tail Suspension Test

Published on: January 28, 2012

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Related Concept Videos

Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...